Research in Maryland
- 1 of 3
- next ›
Biopharmaceutical research companies are conducting or have conducted nearly 3,500 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).
Of the nearly 3,500 clinical trials, 1,775 target or have targeted the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.